HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sara R Goldstein Selected Research

CC 401

9/2015Inhibition of JNK Sensitizes Hypoxic Colon Cancer Cells to DNA-Damaging Agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sara R Goldstein Research Topics

Disease

1Hemolysis
07/2018
1Poisoning
07/2018
1Neoplasms (Cancer)
09/2015
1Hypoxia (Hypoxemia)
09/2015
1Colonic Neoplasms (Colon Cancer)
09/2015

Drug/Important Bio-Agent (IBA)

1Carbon MonoxideIBA
07/2018
1Hemoglobins (Hemoglobin)IBA
07/2018
1IRL 2500IBA
07/2018
1Biological ProductsIBA
07/2018
1Phosphotransferases (Kinase)IBA
09/2015
1Protein Isoforms (Isoforms)IBA
09/2015
1CC 401IBA
09/2015
1Bevacizumab (Avastin)FDA Link
09/2015
1Oxaliplatin (Eloxatin)FDA LinkGeneric
09/2015
1DNA (Deoxyribonucleic Acid)IBA
09/2015

Therapy/Procedure

2Therapeutics
07/2018 - 09/2015
1Drug Therapy (Chemotherapy)
09/2015